vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Hilltop Holdings Inc. (HTH). Click either name above to swap in a different company.
Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $205.4M, roughly 1.5× COLLEGIUM PHARMACEUTICAL, INC). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 8.3%, a 4.7% gap on every dollar of revenue. Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 0.6%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.
COLL vs HTH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $300.5M |
| Net Profit | $17.0M | $39.0M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | 13.0% |
| Revenue YoY | 12.9% | — |
| Net Profit YoY | 35.3% | -12.4% |
| EPS (diluted) | $0.48 | $0.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $300.5M | ||
| Q4 25 | $205.4M | $329.9M | ||
| Q3 25 | $209.4M | $330.2M | ||
| Q2 25 | $188.0M | $303.3M | ||
| Q1 25 | $177.8M | $318.5M | ||
| Q4 24 | $181.9M | $301.1M | ||
| Q3 24 | $159.3M | $305.5M | ||
| Q2 24 | $145.3M | $297.0M |
| Q1 26 | — | $39.0M | ||
| Q4 25 | $17.0M | $41.6M | ||
| Q3 25 | $31.5M | $45.8M | ||
| Q2 25 | $12.0M | $36.1M | ||
| Q1 25 | $2.4M | $42.1M | ||
| Q4 24 | $12.5M | $35.5M | ||
| Q3 24 | $9.3M | $29.7M | ||
| Q2 24 | $19.6M | $20.3M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | 16.1% | ||
| Q3 25 | 29.7% | 18.4% | ||
| Q2 25 | 18.7% | 16.3% | ||
| Q1 25 | 12.2% | 18.1% | ||
| Q4 24 | 20.9% | 14.7% | ||
| Q3 24 | 21.9% | 13.9% | ||
| Q2 24 | 32.7% | 10.0% |
| Q1 26 | — | 13.0% | ||
| Q4 25 | 8.3% | 12.6% | ||
| Q3 25 | 15.0% | 13.9% | ||
| Q2 25 | 6.4% | 11.9% | ||
| Q1 25 | 1.4% | 13.2% | ||
| Q4 24 | 6.9% | 11.8% | ||
| Q3 24 | 5.9% | 9.7% | ||
| Q2 24 | 13.5% | 6.8% |
| Q1 26 | — | $0.64 | ||
| Q4 25 | $0.48 | $0.68 | ||
| Q3 25 | $0.84 | $0.74 | ||
| Q2 25 | $0.34 | $0.57 | ||
| Q1 25 | $0.07 | $0.65 | ||
| Q4 24 | $0.36 | $0.55 | ||
| Q3 24 | $0.27 | $0.46 | ||
| Q2 24 | $0.52 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | — |
| Total DebtLower is stronger | — | $990.8M |
| Stockholders' EquityBook value | $301.7M | $2.2B |
| Total Assets | $1.7B | $15.7B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — |
| Q1 26 | — | $990.8M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $301.7M | $2.2B | ||
| Q3 25 | $274.8M | $2.2B | ||
| Q2 25 | $232.2M | $2.2B | ||
| Q1 25 | $234.4M | $2.2B | ||
| Q4 24 | $228.8M | $2.2B | ||
| Q3 24 | $234.3M | $2.2B | ||
| Q2 24 | $216.6M | $2.1B |
| Q1 26 | — | $15.7B | ||
| Q4 25 | $1.7B | $15.8B | ||
| Q3 25 | $1.6B | $15.6B | ||
| Q2 25 | $1.6B | $15.4B | ||
| Q1 25 | $1.6B | $15.8B | ||
| Q4 24 | $1.7B | $16.3B | ||
| Q3 24 | $1.6B | $15.9B | ||
| Q2 24 | $1.1B | $15.6B |
| Q1 26 | — | 0.46× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $-38.7M | ||
| Q3 25 | $78.4M | $273.0M | ||
| Q2 25 | $72.4M | $-234.6M | ||
| Q1 25 | $55.4M | $5.8M | ||
| Q4 24 | $84.6M | $273.9M | ||
| Q3 24 | $-9.0M | $515.6M | ||
| Q2 24 | $67.4M | $-435.3M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $-55.5M | ||
| Q3 25 | $78.3M | $271.0M | ||
| Q2 25 | $72.4M | $-234.6M | ||
| Q1 25 | $54.6M | $5.0M | ||
| Q4 24 | $84.1M | $266.8M | ||
| Q3 24 | $-9.2M | $513.8M | ||
| Q2 24 | $67.1M | $-437.3M |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | -16.8% | ||
| Q3 25 | 37.4% | 82.1% | ||
| Q2 25 | 38.5% | -77.4% | ||
| Q1 25 | 30.7% | 1.6% | ||
| Q4 24 | 46.2% | 88.6% | ||
| Q3 24 | -5.8% | 168.2% | ||
| Q2 24 | 46.2% | -147.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 5.1% | ||
| Q3 25 | 0.1% | 0.6% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 0.3% | 2.4% | ||
| Q3 24 | 0.2% | 0.6% | ||
| Q2 24 | 0.2% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | -0.93× | ||
| Q3 25 | 2.49× | 5.96× | ||
| Q2 25 | 6.05× | -6.50× | ||
| Q1 25 | 22.92× | 0.14× | ||
| Q4 24 | 6.75× | 7.71× | ||
| Q3 24 | -0.96× | 17.36× | ||
| Q2 24 | 3.44× | -21.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |
